✦ LIBER ✦

Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma

✍ Scribed by Eric W. Schaefer; Shaji Kumar; Angela Dispenzieri; Jacob B. Allred; Morie A. Gertz; Martha Q. Lacy; S. Vincent Rajkumar; Sumithra J. Mandrekar

Book ID: 102106950
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 165 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24767

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short progression-free survival predicts

Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy

✍ Magdalini Migkou; Efstathios Kastritis; Maria Roussou; Maria Gkotzamanidou; Mari 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Oligoclonal and monoclonal bands after s

Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival

✍ Jimenez-Zepeda, Victor H.; Reece, Donna E.; Trudel, Suzanne; Franke, Norman; Win 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 253 KB

Response-adjusted ISS (RaISS) is a simpl

Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma

✍ Alessandro Corso; Monica Galli; Silvia Mangiacavalli; Fausto Rossini; Andrea Noz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views